PUBLISHER: The Business Research Company | PRODUCT CODE: 1994518
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994518
Cheek Augmentation is an aesthetic medical procedure focused on improving the volume, shape, and definition of the cheeks to achieve a more harmonious and youthful facial look. This enhancement can be performed using surgical cheek implants or non-surgical injectable fillers, depending on individual goals and preferences. The treatment enhances facial balance, replenishes age-related volume loss, and improves overall facial attractiveness.
The primary types of cheek augmentation include surgical cheek implants, injectable fillers, and fat grafting or autologous fat transfer. Surgical cheek implants refer to procedures where biocompatible implants are inserted to enhance the contour and volume of the cheeks. These procedures use products such as derma fillers, implants, malar implants, submalar implants, combined implants, and other products. They are performed using techniques including minimally invasive procedures and conventional surgical procedures, and are used by end users including specialty aesthetic clinics, medical spas, and hospitals.
Tariffs are impacting the cheek augmentation market by increasing costs of imported dermal fillers, implant materials, medical-grade polymers, imaging software licenses, and specialized surgical instruments. Aesthetic clinics and hospitals in North America and Europe are most affected due to reliance on imported injectable products and implant systems, while Asia-Pacific faces cost pressures on premium aesthetic device imports. These tariffs are increasing procedure costs and influencing pricing strategies. However, they are also encouraging local filler manufacturing, regional supplier development, and innovation in cost-effective aesthetic treatment solutions.
The cheek augmentation market research report is one of a series of new reports from The Business Research Company that provides cheek augmentation market statistics, including cheek augmentation industry global market size, regional shares, competitors with a cheek augmentation market share, detailed cheek augmentation market segments, market trends and opportunities, and any further data you may need to thrive in the cheek augmentation industry. This cheek augmentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cheek augmentation market size has grown strongly in recent years. It will grow from $3.75 billion in 2025 to $4.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing acceptance of cosmetic procedures, growth of medical aesthetics clinics, availability of advanced dermal fillers, rising influence of aesthetic medicine, expansion of urban cosmetic service providers.
The cheek augmentation market size is expected to see strong growth in the next few years. It will grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cosmetic treatments, growing adoption of AI-assisted facial analysis, expansion of medical tourism for aesthetics, rising focus on personalized beauty solutions, increasing investments in aesthetic technology platforms. Major trends in the forecast period include increasing use of 3d facial imaging for treatment planning, growing demand for non-surgical injectable procedures, rising preference for personalized aesthetic design, expansion of minimally invasive facial contouring, enhanced focus on natural-looking results.
The rising popularity of facial aesthetic treatments is projected to boost the growth of the cheek augmentation market in the coming years. Facial aesthetic treatments are cosmetic procedures aimed at enhancing or restoring facial features to improve appearance and self-confidence. The demand for such treatments is increasing due to a growing aging population seeking a youthful look, as natural facial volume loss and wrinkles motivate many individuals to pursue procedures that restore a more youthful appearance and improve self-esteem. Cheek augmentation supports facial aesthetic treatments by replenishing mid-face volume, enhancing facial contours, improving symmetry, and creating a natural lifting effect, contributing to a more youthful, balanced, and rejuvenated overall facial appearance. For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing surgical procedures by 2%, with plastic surgeries rising by 5% while minimally invasive procedures grew 7% year-over-year. Therefore, the rising demand for facial aesthetic treatments is propelling the growth of the cheek augmentation market.
Leading companies operating in the cheek augmentation market are focusing on developing innovative products, such as advanced hyaluronic acid-based dermal fillers, to enhance facial volume and contour with improved safety and longer-lasting results. Advanced hyaluronic acid-based dermal fillers are injectable gels formulated to mimic the body's natural hyaluronic acid, helping to restore cheek volume, enhance contour, and improve facial symmetry by attracting and retaining moisture for a smoother, more youthful appearance. For example, in January 2026, Revance Therapeutics Inc., a US-based pharmaceutical company, and TEOXANE SA., a Switzerland-based manufacturing company, received U.S. Food and Drug Administration (FDA) approval for RHA Dynamic Volume, a next-generation hyaluronic acid dermal filler developed for cheek augmentation and the correction of age-related midface contour deficiencies. The product is engineered using Preserved Network Technology, a gentle, heat-free crosslinking process that helps maintain the natural structure of hyaluronic acid, resulting in high dynamic strength, elasticity, and durability compared with conventional fillers. It is designed to provide deep structural support while adapting to facial movement, allowing natural-looking results both at rest and in motion, and has demonstrated comparable clinical effectiveness with fewer treatment sessions and touch-ups in late-stage clinical studies.
In February 2025, Crown Laboratories Inc., a US-based skincare company, acquired Revance Therapeutics Inc. for an undisclosed amount. With this acquisition, Crown Laboratories aimed to reinforce and expand its position in the global aesthetics and skincare market by combining its existing product portfolio with Revance's innovative aesthetic and therapeutic offerings to drive growth and achieve competitive scale. Revance Therapeutics Inc. is a US-based biotechnology company specializing in cheek augmentation.
Major companies operating in the cheek augmentation market are AbbVie Inc., LG Chem Life Sciences Ltd., Stryker Corporation, Zimmer Biomet Holdings Inc., Merz Aesthetics GmbH, KLS Martin Group, Sinclair Pharma Limited, Medartis Holding AG, Hugel Inc., Revance Therapeutics Inc., Medytox Inc., Anika Therapeutics Inc., Croma-Pharma GmbH, GC Aesthetics Ltd., Regen Lab SA, Teoxane Laboratories SA, Human Med AG, BioPlus Co. Ltd., Polytech Health & Aesthetics GmbH, and Sebbin Group.
North America was the largest region in the cheek augmentation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cheek augmentation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cheek augmentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cheek augmentation market includes revenues earned by entities through D facial imaging and treatment planning, personalized aesthetic design services, anesthesia and operating room services, revision and corrective procedures, complication management, non-surgical touch-up and maintenance treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cheek Augmentation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cheek augmentation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cheek augmentation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cheek augmentation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.